BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30418940)

  • 1. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
    Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
    Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified microdosimetric kinetic model for relative biological effectiveness calculation.
    Chen Y; Li J; Li C; Qiu R; Wu Z
    Phys Med Biol; 2017 Dec; 63(1):015008. PubMed ID: 29240558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model.
    Wang W; Sun W; Shen H; Zhao J
    Radiat Oncol; 2023 May; 18(1):82. PubMed ID: 37198685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
    Zhang L; Wang W; Hu J; Lu J; Kong L
    Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Monte Carlo approach to the microdosimetric kinetic model to account for dose rate time structure effects in ion beam therapy with application in treatment planning simulations.
    Manganaro L; Russo G; Cirio R; Dalmasso F; Giordanengo S; Monaco V; Muraro S; Sacchi R; Vignati A; Attili A
    Med Phys; 2017 Apr; 44(4):1577-1589. PubMed ID: 28130821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
    Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
    Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma.
    Wang W; Huang Z; Sheng Y; Zhao J; Shahnazi K; Zhang Q; Jiang G
    Radiother Oncol; 2020 Mar; 144():30-36. PubMed ID: 31710941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose.
    Dale JE; Molinelli S; Vischioni B; Vitolo V; Bonora M; Magro G; Mairani A; Hasegawa A; Ohno T; Dahl O; Valvo F; Fossati P
    Front Oncol; 2020; 10():531344. PubMed ID: 33330020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extension of matRad with a modified microdosimetric kinetic model for carbon ion treatment planning: Comparison with Monte Carlo calculation.
    Yoon E; Kim JI; Park JM; Choi CH; Jung S
    Med Phys; 2023 Sep; 50(9):5884-5896. PubMed ID: 37162309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models.
    Góra J; Grosshagauer S; Fossati P; Mumot M; Stock M; Schafasand M; Carlino A
    J Appl Clin Med Phys; 2024 Mar; ():e14321. PubMed ID: 38436509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy.
    Steinsträter O; Grün R; Scholz U; Friedrich T; Durante M; Scholz M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):854-60. PubMed ID: 22483698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trichrome beam model for biological dose calculation in scanned carbon-ion radiotherapy treatment planning.
    Inaniwa T; Kanematsu N
    Phys Med Biol; 2015 Jan; 60(1):437-51. PubMed ID: 25658007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
    Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beam interruption time on tumor control probability in single-fractionated carbon-ion radiotherapy for non-small cell lung cancer.
    Inaniwa T; Kanematsu N; Suzuki M; Hawkins RB
    Phys Med Biol; 2015 May; 60(10):4105-21. PubMed ID: 25933161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
    Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
    Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mayo Clinic Florida microdosimetric kinetic model of clonogenic survival: formalism and first benchmark against
    Parisi A; Beltran CJ; Furutani KM
    Phys Med Biol; 2022 Sep; 67(18):. PubMed ID: 36097336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.